This content is machine translated Pulmonary arterial hypertension beyond the guideline. IPAH or what else? – IPAH with pulmonary comorbidity Pulmonary hypertension is divided into 5 distinct groups, with group 1 reflecting pulmonary arterial hypertension (PAH). The PH-specific drug therapies approved to date interfere with three different signaling pathways (NO… CME-Test
View Post 4 min This content is machine translated Heart failure (HFpEF) Is cardiac amyloidosis hiding behind it? In those over 65, heart failure is the most common reason for hospitalization. Clarification of the cause of the disease is essential to direct patients to targeted therapy. Patients with…
View Post 5 min This content is machine translated High performance chargers for electric vehicles EMI risk for patients with pacemakers and defibrillators? Battery-powered electric vehicles and their charging stations are a potential source of electromagnetic interference (EMI) for patients with cardiac implantable electronic devices (CIEDs). The new “high power” charging stations have…
View Post 7 min This content is machine translated SCORE2 diabetes 10-year estimate of cardiovascular risk in type 2 diabetes. To develop and validate a recalibrated prediction model (SCORE2-Diabetes) to estimate the 10-year risk of cardiovascular disease in individuals aged over 40 years with type 2 diabetes in four different…
View Post 8 min This content is machine translated Catheter ablation Premature ventricular complexes in the intramural outflow tract Ablation of ventricular outflow tract arrhythmias may be limited by the deep intramural location of the arrhythmogenic source. Therefore, a recent study evaluated the acute and long-term outcomes of patients…
View Post 7 min This content is machine translated CLEAR Outcomes Study New results on bempedoic acid Statin-intolerant patients represent a difficult patient group to treat in lipid management. Now, with the CLEAR Outcomes study, it has been shown that a therapeutic option with a beneficial effect…
View Post 5 min This content is machine translated Heart failure in type 2 diabetes Success story of SGLT-2 inhibitors – impressive evidence base. The SGLT(“sodium glucose-linked transporter”)-2 inhibitors have demonstrated cardioprotective effects in addition to antidiabetic effects. The current evidence supports the benefit of several agents of SGLT-2-i in the treatment of heart…
View Post 18 min This content is machine translated Cardiovascular diseases & sleep apnea News from the ominous duo Sleep-disordered breathing is now a recognized cardiac risk factor. It can trigger not only circulatory diseases such as hypertension and heart failure, but also atrial fibrillation. As a result, it…
View Post 11 min This content is machine translated Women's hearts beat differently! Gender-sensitive diagnostics in cardiology To this day, women fight for the legal and social equality of the female sex. In medicine, however, equal treatment oriented toward men can have negative consequences for women. Particularly…
View Post 3 min This content is machine translated Hypertension Systemic thinking, individualized treatment Hypertension is a widespread disease that primarily affects people of advanced age. Reducing levels to the target range requires comprehensive treatment management consisting of lifestyle modification and pharmacotherapy. If this…
View Post 14 min This content is machine translated ESC Guidelines 2022 Cardiovascular management in non-cardiac surgery. Approximately 50% of perioperative causes of death in noncardiac surgery can be attributed to cardiovascular causes. Appropriate preoperative cardiovascular risk assessment can reduce the risk of complications. To this end,… CME-Test
